Mega Lifesciences Balance Sheet Health
Financial Health criteria checks 6/6
Mega Lifesciences has a total shareholder equity of THB9.3B and total debt of THB76.0M, which brings its debt-to-equity ratio to 0.8%. Its total assets and total liabilities are THB14.1B and THB4.8B respectively. Mega Lifesciences's EBIT is THB2.9B making its interest coverage ratio -99.8. It has cash and short-term investments of THB2.7B.
Key information
0.8%
Debt to equity ratio
฿76.00m
Debt
Interest coverage ratio | -99.8x |
Cash | ฿2.72b |
Equity | ฿9.30b |
Total liabilities | ฿4.81b |
Total assets | ฿14.11b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: MEGA's short term assets (THB10.0B) exceed its short term liabilities (THB4.4B).
Long Term Liabilities: MEGA's short term assets (THB10.0B) exceed its long term liabilities (THB376.1M).
Debt to Equity History and Analysis
Debt Level: MEGA has more cash than its total debt.
Reducing Debt: MEGA's debt to equity ratio has reduced from 16.7% to 0.8% over the past 5 years.
Debt Coverage: MEGA's debt is well covered by operating cash flow (2534.9%).
Interest Coverage: MEGA earns more interest than it pays, so coverage of interest payments is not a concern.